Balance Sheet Evercore Inc.

Equities

EVR

US29977A1051

Investment Banking & Brokerage Services

Real-time Estimate Cboe BZX Other stock markets 15:47:55 21/01/2026 GMT			5-day change	1st Jan Change
375.40 ^USD	+2.43%		+2.03%	+9.91%

12:04pm	Prudential Financial's PGIM to Invest Up to $1 Billion in Private Credit Secondaries Over Two Years	MT
01-20	GSK plc entered a definitive agreement to acquire RAPT Therapeutics, Inc. for $1.6 billion.	CI

91.YfoYOFyKXhZmg29DT733ycDRrfouqT3Pw6I4NDakXjM.JMJSChjFNXsftxUPfNKd_IXj4LRK0HKetfZrTX7LFGwFrH57KN8XLjbQAA

Published financial data: EVERCORE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Interest Expense, Total	21.41M	17.59M	16.85M	16.72M	16.77M
Net Interest Income	-21.41M	-17.59M	-16.85M	-16.72M	-16.77M
Asset Management Fee	54.4M	65.78M	64.48M	67.04M	79.55M
Underwriting & Investment Banking Fee	2.24B	3.2B	2.72B	2.28B	2.81B
Gain (Loss) on Sale of Investments, Total (Rev)	15.79M	30.19M	-27.23M	31.72M	34.39M
Other Revenues, Total	8.7M	2.22M	19.85M	66.24M	71.36M
Revenues Before Provison For Loan Losses	2.29B	3.29B	2.76B	2.43B	2.98B
Total Revenues	2.29B	3.29B	2.76B	2.43B	2.98B
Salaries And Other Employee Benefits	1.37B	1.85B	1.7B	1.66B	1.97B
Cost of Services Provided, Total	249M	261M	310M	342M	401M
Depreciation & Amortization - (IS) - (Collected)	26.24M	28.1M	27.71M	24.35M	24.47M
Other Operating Expenses	42.94M	40.63M	27.75M	41.14M	46.06M
Total Operating Expenses	1.69B	2.18B	2.06B	2.06B	2.45B
Operating Income	604M	1.11B	699M	362M	535M
Income (Loss) on Equity Invest.	14.4M	14.16M	8M	6.66M	6.23M
Currency Exchange Gains (Loss)	-	-	-	-	-658K
EBT, Excl. Unusual Items	619M	1.12B	707M	369M	540M
Restructuring Charges	-43.32M	-8.55M	-3.13M	-2.92M	-7.3M
Total Merger & Related Restructuring Charges	-562K	-7K	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) on Sale of Assets	-30.81M	-	-	-	-
Asset Writedown	-3.32M	-	-	-	-
Other Unusual Items	-	4.37M	-	-	-
EBT, Incl. Unusual Items	541M	1.12B	704M	366M	533M
Income Tax Expense	128M	248M	173M	80.57M	115M
Earnings From Continuing Operations	413M	869M	531M	285M	418M
Net Income to Company	413M	869M	531M	285M	418M
Minority Interest	-62.11M	-128M	-54.9M	-29.74M	-39.46M
Net Income - (IS)	351M	740M	477M	255M	378M
Net Income to Common Incl Extra Items	351M	740M	477M	255M	378M
Net Income to Common Excl. Extra Items	351M	740M	477M	255M	378M
Per Share Items
Net EPS - Basic	8.64	18.48	12.15	6.71	9.86
Basic EPS - Continuing Operations	8.64	18.48	12.15	6.71	9.86
Basic Weighted Average Shares Outstanding	40.55M	40.05M	39.22M	38.1M	38.36M
Net EPS - Diluted	8.22	17.08	11.61	6.37	9.08
Diluted EPS - Continuing Operations	8.22	17.08	11.61	6.37	9.08
Diluted Weighted Average Shares Outstanding	42.62M	43.32M	41.04M	40.1M	41.65M
Normalized Basic EPS	8.01	14.28	9.87	5.27	7.78
Normalized Diluted EPS	7.62	13.2	9.43	5.01	7.16
Dividend Per Share	2.35	2.72	2.88	3.04	3.2
Payout Ratio	30.4	16.05	26.71	50.05	35.91
Supplemental Items
Total Revenues (As Reported)	2.29B	3.31B	2.78B	2.44B	3B
Effective Tax Rate - (Ratio)	23.7	22.21	24.52	22.03	21.65
Current Domestic Taxes	93.97M	193M	133M	63.04M	81.76M
Current Foreign Taxes	20.36M	25.64M	40.68M	20.43M	25.58M
Total Current Taxes	114M	219M	173M	83.46M	107M
Deferred Domestic Taxes	10.53M	30.84M	5.04M	3.69M	22.57M
Deferred Foreign Taxes	3.29M	-1.76M	-5.89M	-6.58M	-14.5M
Total Deferred Taxes	13.82M	29.08M	-855K	-2.89M	8.07M
Normalized Net Income	325M	572M	387M	201M	298M
Supplemental Operating Expense Items
Stock-Based Comp., G&A Exp. (Total)	207M	224M	271M	304M	349M
Stock-Based Comp., Other (Total)	10.92M	-	-	-	-
Total Stock-Based Compensation	218M	224M	271M	304M	349M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	830M	578M	663M	597M	873M
Cash & Securities Segregated	-	-	-	-	-
Securities Owned	-	-	-	-	-
Securities Purchased Under Agreements To Resell	-	-	-	-	-
Accounts Receivable, Total	469M	454M	560M	551M	585M
Other Receivables	441K	475K	368K	323K	146K
Gross Property Plant And Equipment	559M	578M	568M	729M	736M
Accumulated Depreciation	-140M	-166M	-187M	-213M	-151M
Net Property Plant And Equipment	419M	412M	381M	516M	584M
Goodwill	129M	128M	123M	125M	124M
Other Intangibles, Total	698K	336K	-	-	-
Investment In Debt and Equity Securities	981M	1.51B	1.18B	1.23B	1.28B
Other Current Assets, Total	193M	361M	374M	330M	357M
Deferred Tax Assets Long-Term (Collected)	258M	248M	257M	266M	285M
Deferred Charges Long-Term	-	9.42M	11.44M	17.04M	18.09M
Other Long-Term Assets, Total	91.12M	102M	71.19M	73.43M	67.44M
Total Assets	3.37B	3.8B	3.62B	3.7B	4.17B
Liabilities
Accounts Payable, Total	37.96M	31.63M	28.81M	25.99M	29.04M
Accrued Expenses, Total	879M	1.11B	918M	763M	1.02B
Short-Term Borrowings	851K	-	-	-	-
Current Portion of Long-Term Debt	37.97M	-	-	-	37.95M
Current Portion of Leases	42.87M	47.32M	37.97M	36.26M	55.25M
Long-Term Debt	339M	376M	372M	374M	336M
Long-Term Leases	300M	297M	278M	434M	494M
Current Income Taxes Payable	15.35M	20.98M	9.84M	5.42M	4.78M
Unearned Revenue, Current	9.37M	9.26M	5.07M	3.52M	3.58M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	40.98M	78.23M	70.36M	75.7M	75.12M
Unearned Revenue Non Current	147K	147K	-	-	-
Other Non Current Liabilities	179M	196M	174M	203M	172M
Total Liabilities	1.88B	2.17B	1.89B	1.92B	2.23B
Common Stock, Total	722K	748K	797K	821K	848K
Additional Paid In Capital	2.27B	2.46B	2.86B	3.16B	3.51B
Retained Earnings	799M	1.42B	1.77B	1.89B	2.13B
Treasury Stock	-1.82B	-2.55B	-3.07B	-3.45B	-3.9B
Comprehensive Income and Other	-9.76M	-12.09M	-27.94M	-26.54M	-36.06M
Total Common Equity	1.23B	1.32B	1.54B	1.58B	1.71B
Minority Interest	258M	315M	190M	206M	234M
Total Equity	1.49B	1.64B	1.73B	1.78B	1.94B
Total Liabilities And Equity	3.37B	3.8B	3.62B	3.7B	4.17B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	42.02M	38.4M	38.6M	38.68M	39.12M
ECS Total Common Shares Outstanding	40.75M	37.9M	38.35M	37.77M	38.12M
Book Value / Share	30.21	34.84	40.08	41.75	44.8
Tangible Book Value	1.1B	1.19B	1.41B	1.45B	1.58B
Tangible Book Value Per Share	27.02	31.44	36.86	38.42	41.54
Total Debt	720M	721M	688M	844M	923M
Net Debt	-109M	143M	24.42M	248M	50.27M
Equity Method Investments, Total	59.51M	58.59M	36.9M	36.88M	12.62M
Full Time Employees	1.78K	1.93K	2.1K	2.17K	2.38K
Part Time Employees	18	19.5	21.2	22	23.8

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	351M	740M	477M	255M	378M
Depreciation, Depletion & Amortization	25.08M	28.29M	28.32M	2.39M	-387K
Amortization of Goodwill and Intangible Assets - (CF)	1.6M	362K	336K	-	-
Total Depreciation, Depletion & Amortization	26.68M	28.66M	28.65M	2.39M	-387K
(Gain) Loss On Sale of Asset - (CF)	35.25M	1.25M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-8.68M	-24.23M	16.46M	-34.67M	-33.68M
Total Asset Writedown	3.32M	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-1.64M	1.1M	3.04M	-192K	7.38M
Stock-Based Compensation (CF)	367M	422M	467M	515M	570M
Provision and Write-off of Bad Debts	6.88M	-60K	5.51M	5.56M	2.33M
Change in Accounts Receivable	-78.57M	16.03M	-46.08M	11.27M	-54.59M
Change in Accounts Payable	-796K	-5.5M	-1.09M	-966K	1.74M
Change In Income Taxes	11.95M	5.63M	-11.14M	-4.56M	-643K
Change in Other Net Operating Assets (Collected)	151M	1.39M	-503M	-361M	28.65M
Other Operating Activities	115M	198M	95.57M	69M	89.32M
Cash from Operations	978M	1.38B	531M	458M	988M
Capital Expenditure	-53.33M	-27.97M	-23.19M	-20.05M	-30.1M
Cash Acquisitions	-	-	-	-	-
Divestitures	679K	-	-	-	-
Investment in Marketable and Equity Securities, Total	-431M	-678M	336M	35.67M	-37.33M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-484M	-706M	313M	15.62M	-67.43M
Short Term Debt Issued, Total	-	-	67M	-	-
Long-Term Debt Issued, Total	-	38M	-	-	-
Total Debt Issued	-	38M	67M	-	-
Short Term Debt Repaid, Total	-	-	-67M	-	-
Long-Term Debt Repaid, Total	-	-38M	-	-	-
Total Debt Repaid	-	-38M	-67M	-	-
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-147M	-730M	-550M	-392M	-451M
Common Dividends Paid	-107M	-119M	-127M	-128M	-136M
Common & Preferred Stock Dividends Paid	-107M	-119M	-127M	-128M	-136M
Other Financing Activities, Total	-53.8M	-76.87M	-58.02M	-37.4M	-42.19M
Cash from Financing	-308M	-925M	-736M	-557M	-629M
Foreign Exchange Rate Adjustments	7.63M	-4.62M	-24.28M	17.02M	-15.54M
Net Change in Cash	194M	-251M	84.83M	-66.64M	277M
Supplemental Items
Cash Interest Paid	23.75M	17.33M	16.86M	16.18M	16.21M
Cash Income Tax Paid (Refund)	111M	192M	218M	74.64M	98.2M
Net Debt Issued / Repaid	-	0	0	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	13.83	24.22	14.32	7.79	10.61
Return On Equity %	31.55	55.59	31.62	16.26	22.43
Return on Common Equity	33.38	58.02	33.36	16.41	23.03
Margin Analysis
Gross Profit Margin %	95.91	97.23	95.54	93.88	94.16
SG&A Margin	66.56	61.46	68.22	76.26	73.84
Income From Continuing Operations Margin %	17.98	26.44	19.24	11.76	14.02
Net Income Margin %	15.28	22.53	17.25	10.53	12.69
Net Avail. For Common Margin %	15.28	22.53	17.25	10.53	12.69
Normalized Net Income Margin	14.15	17.41	14.01	8.27	10.01
Asset Turnover
Asset Turnover	0.77	0.92	0.74	0.66	0.76
Short Term Liquidity
Current Ratio	1.4	1.07	1.49	1.62	1.48
Quick Ratio	1.22	0.8	1.14	1.26	1.19
Operating Cash Flow to Current Liabilities	0.92	1.07	0.5	0.5	0.8
Long Term Solvency
Total Debt/Equity	48.38	44.09	39.84	47.37	47.55
Total Debt / Total Capital	32.6	30.6	28.49	32.14	32.23
LT Debt/Equity	42.89	41.2	37.64	45.34	42.75
Long-Term Debt / Total Capital	28.91	28.59	26.92	30.76	28.97
Total Liabilities / Total Assets	55.82	57	52.32	51.87	53.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.24	43.16	-15.92	-12.17	22.85
Gross Profit, 1 Yr. Growth %	17.51	45.13	-17.39	-13.69	23.21
Earnings From Cont. Operations, 1 Yr. Growth %	16.69	110.47	-38.82	-46.33	46.46
Net Income, 1 Yr. Growth %	17.87	111.12	-35.62	-46.39	48.07
Normalized Net Income, 1 Yr. Growth %	40.44	76.19	-32.33	-48.15	48.64
Diluted EPS Before Extra, 1 Yr. Growth %	19.3	107.79	-32.03	-45.13	42.54
Common Equity, 1 Yr. Growth %	41.53	7.26	16.39	2.61	8.29
Total Assets, 1 Yr. Growth %	29.72	12.81	-4.78	2.27	12.71
Tangible Book Value, 1 Yr. Growth %	49.48	8.23	18.61	2.68	9.08
Cash From Operations, 1 Yr. Growth %	93.85	41.55	-61.63	-13.82	115.78
Capital Expenditures, 1 Yr. Growth %	-24.69	-47.55	-17.1	-13.54	50.14
Dividend Per Share, 1 Yr. Growth %	4.91	15.74	5.88	5.56	5.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.42	27.88	9.71	-14.07	3.87
Gross Profit, 2 Yr. CAGR %	6.43	30.59	9.5	-15.56	3.12
Earnings From Cont. Operations, 2 Yr. CAGR %	-3.47	56.71	13.48	-42.7	-11.34
Net Income, 2 Yr. CAGR %	-3.6	57.74	16.59	-41.25	-10.9
Normalized Net Income, 2 Yr. CAGR %	7.27	57.3	12.18	-40.77	-12.21
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.66	57.45	18.84	-38.93	-11.56
Common Equity, 2 Yr. CAGR %	27.42	23.21	11.74	9.28	5.41
Total Assets, 2 Yr. CAGR %	25.93	20.97	3.64	-1.32	7.37
Tangible Book Value, 2 Yr. CAGR %	33.66	27.19	13.3	10.36	5.83
Cash From Operations, 2 Yr. CAGR %	7.31	65.65	-26.3	-42.5	36.37
Capital Expenditures, 2 Yr. CAGR %	26.5	-37.15	-34.06	-15.34	13.94
Dividend Per Share, 2 Yr. CAGR %	11.21	10.19	10.7	5.72	5.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.96	16.74	11.2	1.87	-3.19
Gross Profit, 3 Yr. CAGR %	13.26	18.02	12.11	1.15	-4.23
Earnings From Cont. Operations, 3 Yr. CAGR %	32.05	25.17	14.54	-11.59	-21.65
Net Income, 3 Yr. CAGR %	40.85	25.19	17.01	-10.01	-20.05
Normalized Net Income, 3 Yr. CAGR %	20.98	26.57	18.74	-13.26	-19.51
Diluted EPS Before Extra, 3 Yr. CAGR %	43.19	27.04	19	-8.15	-18.99
Common Equity, 3 Yr. CAGR %	31.29	20.31	20.9	8.61	8.95
Total Assets, 3 Yr. CAGR %	28.6	21.39	11.69	3.18	3.15
Tangible Book Value, 3 Yr. CAGR %	41.32	24.58	24.26	9.64	9.93
Cash From Operations, 3 Yr. CAGR %	24.48	17.69	1.73	-22.36	-10.64
Capital Expenditures, 3 Yr. CAGR %	19.44	-5.67	-31.08	-27.83	2.48
Dividend Per Share, 3 Yr. CAGR %	18.28	12.7	8.74	8.96	5.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.41	17.93	11.05	3.28	8.21
Gross Profit, 5 Yr. CAGR %	14.23	19.25	11.74	3.23	8.42
Earnings From Cont. Operations, 5 Yr. CAGR %	48.22	42.37	24.28	-8.42	3.39
Net Income, 5 Yr. CAGR %	52.24	47.08	30.59	-7.5	4.93
Normalized Net Income, 5 Yr. CAGR %	26.79	34.04	16.12	-6.59	5.23
Diluted EPS Before Extra, 5 Yr. CAGR %	53.01	47.7	32.9	-5.22	5.68
Common Equity, 5 Yr. CAGR %	19.53	20.15	23.09	15.78	14.45
Total Assets, 5 Yr. CAGR %	17.91	18	17.97	11.74	9.94
Tangible Book Value, 5 Yr. CAGR %	29.95	28.74	29.36	18.68	16.53
Cash From Operations, 5 Yr. CAGR %	21.62	26.84	0.93	-11.63	14.38
Capital Expenditures, 5 Yr. CAGR %	26.93	8.69	-5.82	-9.66	-15.73
Dividend Per Share, 5 Yr. CAGR %	15.36	16.45	15.19	9.86	7.39